Honor has officially rolled out the Android 16 Beta 3 Developer Preview for its latest flagship, the Magic 7 Pro, making it one of the first non-Google phones globally to offer access to the ...

Honor Magic 7 Pro is now getting Android 16 beta 3. This is still a Developer Preview and is meant for devs and advanced users. You can head this way for a detailed guide on how to get the beta ...

Ahead of Android 16’s stable release, Google today is rolling out QPR1 Beta 1 to Pixel devices with the Material 3 Expressive redesign ... Pixel 6a, Pixel 7, Pixel 7 Pro, Pixel 7a, Pixel ...

Honor has become one of the first non-Google smartphone manufacturers to introduce the Android 16 Beta 3 Developer Preview, now available for its flagship model, the Magic 7 Pro. Starting May 7 ...

Android 16 QPR1 Beta 1 is out now This includes Android's big Material 3 Expressive redesign However, these changes won't roll out with the first version of Android 16 Hot on the heels of Google ...

Today, Google released Android 16 QPR1 Beta 1, bringing some of the most highly anticipated Material 3 Expressive changes ... Pixel 6a, Pixel 7, Pixel 7 Pro, Pixel 7a, Pixel 8, Pixel 8 Pro ...

With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver disease franchise.

The big Material 3 Expressive ... and QPR1 Beta 1 on the right. If you want to quickly install Android 16 QPR1 Beta 1 on your compatible Pixel 6, Pixel 6 Pro, Pixel 6a, Pixel 7, Pixel 7 Pro ...

AI I tested Gemini 2.5 Pro vs Claude 4 Sonnet with the same 7 prompts — here’s who came ... AI I just tested ChatGPT deep research vs Grok-3 with 5 prompts — here's the winner AI I tested ...

Google's new design language Material 3 Expressive lands as a beta version on Pixel devices. Google says the stable version will be released “later this year”. Google has released a new beta ...

That is below the 30% rate reported at an interim stage of the study at the International Liver Congress earlier this year, but still sufficient for GSK to take the drug forward into a phase 3 ...